natgillin/translations-raw huggingface dataset:
Clopidogrel Acino Pharma GmbH can be started between a few days and 35 days after the attack; patients who have had a recent ischaemic stroke (stroke caused by failure of the blood supply to part of the brain).
Zdravilo Clopidogrel Acino Pharma GmbH se lahko začne jemati od nekaj dni po napadu do 35 dni po njem; bolnikom, ki so nedavno utrpeli ishemično kap (kap, ki jo povzroči pomanjkljiva oskrba določenega dela možganov s krvjo).
Clopidogrel Acino Pharma GmbH can be started between seven days and six months after the stroke; patients with peripheral arterial disease (problems with blood flow in the arteries); The medicine can only be obtained with a prescription.
Zdravilo Clopidogrel Acino Pharma GmbH se lahko začne jemati od sedem dni po napadu do šest mesecev po njem; bolnikom s periferno arterijsko boleznijo (težavami s pretokom krvi v arterijah); Zdravilo se dobi samo na recept.
Clopidogrel Acino Pharma GmbH is a ‘generic medicine’.
Clopidogrel Acino Pharma GmbH je „generično zdravilo“.
Clopidogrel Acino Pharma GmbH is not intended for use in children or adolescents.
Zdravilo Klopidogrel Acino Pharma GmbH ni namenjeno za uporabo pri otrocih ali mladostnikih.
Clopidogrel Acino Pharma GmbH is unlikely to affect your ability to drive or to use machines.
Ni verjetno, da bi zdravilo Klopidogrel Acino Pharma GmbH vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
Clopidogrel Acino Pharma GmbH may be taken with or without food.
Zdravilo Klopidogrel Acino Pharma GmbH lahko jemljete s hrano ali brez nje.
Clopidogrel Acino Pharma is a ‘generic medicine’.
Clopidogrel Acino Pharma je „generično zdravilo“.
Clopidogrel Acino Pharma is not intended for use in children or adolescents.
Zdravilo Klopidogrel Acino Pharma ni namenjeno za uporabo pri otrocih ali mladostnikih.
Clopidogrel Acino Pharma is unlikely to affect your ability to drive or to use machines.
Ni verjetno, da bi zdravilo Klopidogrel Acino Pharma vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
Clopidogrel Acino Pharma may be taken with or without food.
Zdravilo Klopidogrel Acino Pharma lahko jemljete s hrano ali brez nje.
Clopidogrel Acino with food and drink
Zdravilo Klopidogrel Acino skupaj s hrano in pijačo
Clopidogrel and ASA: From the data collected in the phase III study RE-LY (see section 5.1) it was observed that the concomitant use of antiplatelets, ASA or clopidogrel approximately doubles major bleeding rates with both dabigatran etexilate and warfarin (see section 4.4).
Klopidogrel in ASK: Podatki iz III. faze študije RE-LY (glejte poglavje 5.1) kažejo, da se pri sočasni uporabi antitrombotikov, ASK ali klopidogrela, približno podvoji odstotek večjih krvavitev, tako pri dabigatran eteksilatu kot varfarinu (glejte poglavje 4.4).
Clopidogrel and the main circulating (inactive) metabolite bind reversibly in vitro to human plasma proteins (98% and 94% respectively).
Klopidogrel in glavni krožeči (neaktivni) presnovek se in vitro reverzibilno vežeta na humane plazemske beljakovine (98- oz.
Clopidogrel Apotex 75 mg film-coated tablets
Clopidogrel Apotex 75 mg filmsko obložene tablete
Clopidogrel Apotex can be started between a few days and 35 days after the attack; recently had an ischaemic stroke (stroke caused by failure of the blood supply to part of the brain).
Zdravilo Clopidogrel Apotex se lahko začne jemati nekaj dni po napadu in do 35 dni po njem; so nedavno utrpeli ishemično kap (kap, ki jo povzroči neoskrba določenega dela možganov s krvjo).
Clopidogrel Apotex is a ‘generic medicine’.
Zdravilo Clopidogrel Apotex je „generično zdravilo“.
Clopidogrel Apotex is unlikely to affect your ability to drive or to use machines.
Ni verjetno, da bi zdravilo Clopidogrel Apotex vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
Clopidogrel Apotex may be taken with or without food.
Zdravilo Clopidogrel Apotex lahko jemljete s hrano ali brez nje.
Clopidogrel Apotex with food and drink
Zdravilo Clopidogrel Apotex skupaj s hrano in pijačo
Clopidogrel BGR 75 mg film-coated tablets Clopidogrel
Clopidogrel BGR 75 mg filmsko obložene tablete klopidogrel
Clopidogrel BGR can be given to the following groups of patients: patients who have recently had a myocardial infarction (heart attack).
Zdravilo Clopidogrel BGR se lahko daje naslednjim skupinam bolnikov: bolnikom, ki so nedavno doživeli miokardni infarkt (srčni napad).
Clopidogrel BGR can be started between a few days and 35 days after the attack; patients who have had a recent ischaemic stroke (stroke caused by failure of the blood supply to part of the brain).
Zdravilo Clopidogrel BGR se lahko začne jemati od nekaj dni po napadu do 35 dni po njem; bolnikom, ki so nedavno utrpeli ishemično kap (kap, ki jo povzroči pomanjkljiva oskrba določenega dela možganov s krvjo).
Clopidogrel BGR can be started between seven days and six months after the stroke; patients with peripheral arterial disease (problems with blood flow in the arteries);
Zdravilo Clopidogrel BGR se lahko začne jemati od sedem dni po napadu do šest mesecev po njem;
Clopidogrel BGR contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products.
Clopidogrel BGR vsebuje klopidogrel in spada v skupino zdravil, ki se imenujejo zaviralci agregacije trombocitov.
Clopidogrel BGR contains hydrogenated castor oil
Clopidogrel BGR vsebuje hidrogenirano ricinusovo olje
Clopidogrel BGR contains hydrogenated castor oil which may cause stomach upset and diarrhoea.
Zdravilo vsebuje hidrogenirano ricinusovo olje, ki lahko razdraži želodec in povzroči drisko.
Clopidogrel BGR contains lactose
Clopidogrel BGR vsebuje laktozo
Clopidogrel BGR is a ‘generic medicine’.
Clopidogrel BGR je „generično zdravilo“.
Clopidogrel BGR is unlikely to affect your ability to drive or to use machines.
Ni verjetno, da bi zdravilo Clopidogrel BGR vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
Clopidogrel BMS 300 mg film-coated tablets
Clopidogrel BMS 300 mg filmsko obložene tablete
Clopidogrel BMS 300 mg film-coated tablets clopidogrel
Clopidogrel BMS 300 mg filmsko obložene tablete klopidogrel
Clopidogrel BMS 300 mg film-coated tablets Sanofi Winthrop Industrie
Clopidogrel BMS 300 mg filmsko obložene tablete Sanofi Winthrop Industrie
Clopidogrel BMS 300-mg film-coated tablets are oblong, pink, engraved on one side with the number ‘300’ and on the other side with the number ‘1332’.
Clopidogrel BMS 300 mg filmsko obložene tablete so podolgovate, rožnate, z vtisnjeno številko “300” na eni strani in številko “1332” na drugi strani.
Clopidogrel BMS 75 mg film-coated tablets
Clopidogrel BMS 75 mg filmsko obložene tablete
Clopidogrel BMS 75-mg film-coated tablets are round, biconvex, pink, engraved on one side with the number ‘75’ and on the other side with the number ‘1171’.
Clopidogrel BMS 75 mg filmsko obložene tablete so okrogle, bikonveksne , rožnate tablete, z vtisnjeno številko “75” na eni strani in številko “1171” na drugi strani.
Clopidogrel BMS also contains hydrogenated castor oil which may cause stomach upset or diarrhoea.
Zdravilo Clopidogrel BMS vsebuje tudi hidrogenirano ricinusovo olje, ki lahko povzroči želodčne motnje ali drisko.
Clopidogrel BMS can be given to the following groups of patients: patients who have recently had a myocardial infarction (heart attack).
Zdravilo Clopidogrel BMS se lahko daje naslednjim skupinam bolnikov: bolnikom, ki so nedavno doživeli miokardni infarkt (srčni napad).
Clopidogrel BMS can be started between a few days and 35 days after the attack; patients who have had a recent ischaemic stroke (stroke caused by the failure of the blood supply to part of the brain).
Zdravilo Clopidogrel BMS se lahko začne jemati nekaj dni po napadu do 35 dni po njem; bolnikom, ki so nedavno utrpeli ishemično kap (kap, ki jo povzroči pomanjkljiva oskrba določenega dela možganov s krvjo).
Clopidogrel BMS can be started between seven days and six months after the stroke;
Zdravilo Clopidogrel BMS se lahko začne jemati od sedem dni po napadu in do šest mesecev po njem;
Clopidogrel BMS can be used in patients who are having a heart attack with an ‘ST segment elevation’ (an abnormal reading on the ECG or electrocardiogram) when the doctor thinks that they would benefit from the treatment.
Zdravilo Clopidogrel BMS se lahko uporablja pri bolnikih, ki so imeli srčni napad z „elevacijo ST spojnice“ (nenormalni zapis na EKG ali elektrokardiogramu), če zdravnik meni, da bi jim zdravilo lahko pomagalo.
Clopidogrel BMS contains lactose.
Zdravilo Clopidogrel BMS vsebuje laktozo .
Clopidogrel BMS is not intended for use in children or adolescents.
Klopidogrel ni namenjen za uporabo pri otrocih ali mladostnikih.
Clopidogrel BMS is taken to prevent blood clots (thrombi) forming in hardened blood vessels (arteries), a process known as atherothrombosis, which can lead to atherothrombotic events (such as stroke, heart attack, or death).
Clopidogrel BMS se jemlje za preprečevanje nastanka krvnih strdkov (trombov) v otrdelih krvnih žilah (arterijah), proces je znan kot aterotromboza in lahko vodi do aterotrombotičnih dogodkov (kot so kap, srčni napad ali smrt).
Clopidogrel BMS may be taken with or without food.
Klopidogrel lahko jemljete s hrano ali brez nje.
Clopidogrel dura 75 mg
Klopidogrel dura 75 mg
Clopidogrel dura 75 mg film-coated tablets
Klopidogrel dura 75 mg filmsko obložene tablete
Clopidogrel DURA can be given to the following groups of patients: patients who have recently had a myocardial infarction (heart attack).
Zdravilo Clopidogrel DURA se lahko daje naslednjim skupinam bolnikov: bolnikom, ki so nedavno doživeli miokardni infarkt (srčni napad).
Clopidogrel DURA can be started between a few days and 35 days after the attack; patients who have had a recent ischaemic stroke (stroke caused by failure of the blood supply to part of the brain).
Zdravilo Clopidogrel DURA se lahko začne jemati nekaj dni po napadu do 35 dni po njem; bolnikom, ki so nedavno utrpeli ishemično kap (kap, ki jo povzroči pomanjkljiva oskrba določenega dela možganov s krvjo).
Clopidogrel DURA can be started between seven days and six months after the stroke; patients with peripheral arterial disease (problems with blood flow in the arteries).
Zdravilo Clopidogrel DURA se lahko začne jemati od sedem dni po napadu do šest mesecev po njem; bolnikom s periferno arterijsko boleznijo (težavami s pretokom krvi v krvnih žilah).
Clopidogrel dura contains hydrogenated castor oil
Zdravilo Klopidogrel dura vsebuje hidrogenirano ricinusovo olje,
Clopidogrel DURA is a ‘generic medicine’.
Zdravilo Clopidogrel DURA je „generično zdravilo“.
Clopidogrel dura is unlikely to affect your ability to drive or to use machines.
Ni verjetno, da bi zdravilo Klopidogrel dura vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
Clopidogrel has been evaluated for safety in more than 42,000 patients who have participated in clinical studies, including over 30,000 patients treated with clopidogrel plus ASA, and over
Varnost klopidogrela so ocenili pri več kot 42.000 bolnikih, ki so sodelovali v kliničnih študijah.
Clopidogrel has no or negligible influence on the ability to drive and use machines.
Klopidogrel nima ali ima zanernarljiv vpliv na sposobnost za vožnjo in upravljanje strojev.
Clopidogrel HCS
Klopidogrel HCS
Clopidogrel HCS can be given to the following groups of patients: patients who have recently had a myocardial infarction (heart attack).
Zdravilo se lahko daje naslednjim skupinam bolnikov: bolnikom, ki so nedavno doživeli miokardni infarkt (srčni napad).
Clopidogrel HCS can be started between a few days and 35 days after the attack; patients who have had a recent ischaemic stroke (stroke caused by failure of the blood supply to part of the brain).
Zdravilo se lahko začne jemati nekaj dni po napadu do 35 dni po njem; bolnikom, ki so nedavno doživeli ishemično kap (kap, ki jo povzroči prekinitev dotoka krvi v del možganov).
Clopidogrel HCS is a ‘generic medicine’.
Zdravilo Clopidogrel HCS je generično zdravilo.
Clopidogrel HCS is unlikely to affect your ability to drive or to use machines.
Ni verjetno, da bi zdravilo Klopidogrel HCS vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
Clopidogrel HEXAL 75 mg
Klopidogrel HEXAL 75 mg
Clopidogrel HEXAL 75 mg film-coated tablets
Klopidogrel HEXAL 75 mg filmsko obložene tablete
Clopidogrel Hexal can be given to the following groups of patients: patients who have recently had a myocardial infarction (heart attack).
Zdravilo Clopidogrel Hexal se lahko daje naslednjim skupinam bolnikov: bolnikom, ki so nedavno doživeli miokardni infarkt (srčni napad).
Clopidogrel Hexal can be started between a few days and 35 days after the attack; patients who have had a recent ischaemic stroke (stroke caused by failure of the blood supply to part of the brain).
Zdravilo Clopidogrel Hexal se lahko začne jemati od nekaj dni po napadu do 35 dni po njem; bolnikom, ki so nedavno utrpeli ishemično kap (kap, ki jo povzroči pomanjkljiva oskrba določenega dela možganov s krvjo).
Clopidogrel Hexal can be used in patients who are having myocardial infarction with ‘ST segment elevation’ (an abnormal reading on the electrocardiogram or ECG) when the doctor thinks that they would benefit from the treatment.
Zdravilo Clopidogrel Hexal se lahko uporablja pri bolnikih, ki so imeli srčni napad z „dvigom spojnice ST“ (nenormalni zapis na elektrokardiogramu ali EKG), če zdravnik meni, da bi jim zdravilo lahko pomagalo.
Clopidogrel HEXAL contains hydrogenated castor oil which may cause stomach upset and diarrhoea.
Klopidogrel HEXAL vsebuje hidrogenirano ricinusovo olje, ki lahko razdraži želodec in povzroči drisko.
Clopidogrel HEXAL contains hydrogenated castor oil which may cause stomach upset or diarrhoea.
Zdravilo Klopidogrel HEXAL vsebuje hidrogenirano ricinusovo olje, ki lahko povzroči želodčne motnje ali drisko.
Clopidogrel Hexal is a ‘generic medicine’.
Liek s ukončenou platnosťou registrácie
Clopidogrel HEXAL is not intended for use in children or adolescents.
Zdravilo Klopidogrel HEXAL ni namenjeno za uporabo pri otrocih ali mladostnikih.
Clopidogrel HEXAL is unlikely to affect your ability to drive or to use machines.
Ni verjetno, da bi zdravilo Klopidogrel HEXAL vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
Clopidogrel HEXAL may be taken with or without food.
Zdravilo Klopidogrel HEXAL lahko jemljete s hrano ali brez nje.
Clopidogrel is extensively metabolised by the liver.
Klopidogrel se v jetrih izdatno presnovi.
Clopidogrel is first metabolised to a 2-oxo-clopidogrel intermediate metabolite.
Klopidogrel se najprej presnovi v 2-oksoklopidogrel, ki se presnavlja naprej do aktivnega presnovka, ki je tiolski derivat klopidogrela.
Clopidogrel Krka 75 mg film-coated tablets Clopidogrel
Klopidogrel Krka 75 mg filmsko obložene tablete klopidogrel
Clopidogrel Krka can be given to the following groups of patients: patients who have recently had a myocardial infarction (heart attack).
Zdravilo Clopidogrel Krka se lahko daje naslednjim skupinam bolnikov: bolnikom, ki so nedavno doživeli miokardni infarkt (srčni napad).
Clopidogrel Krka can be started between a few days and 35 days after the attack; patients who have had a recent ischaemic stroke (stroke caused by failure of the blood supply to part of the brain).
Zdravilo Clopidogrel Krka se lahko začne jemati nekaj dni po napadu do 35 dni po njem; bolnikom, ki so nedavno utrpeli ishemično kap (kap, ki jo povzroči pomanjkljiva oskrba določenega dela možganov s krvjo).
Clopidogrel Krka can be started between seven days and six months after the stroke; patients with peripheral arterial disease (problems with blood flow in the arteries).
Zdravilo Clopidogrel Krka se lahko začne jemati od sedem dni po napadu do šest mesecev po njem; bolnikom s periferno arterijsko boleznijo (težavami s pretokom krvi v krvnih žilah).
Clopidogrel Krka contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products.
Klopidogrel Krka vsebuje klopidogrel in spada v skupino zdravil, ki se imenujejo zaviralci agregacije trombocitov.
Clopidogrel Krka contains hydrogenated castor oil
Zdravilo Klopidogrel Krka vsebuje hidrogenirano ricinusovo olje
Clopidogrel Krka d.d. contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products.
Clopidogrel Krka d.d. vsebuje klopidogrel in spada v skupino zdravil, ki se imenujejo zaviralci agregacije trombocitov.
Clopidogrel Krka d.d. contains hydrogenated castor oil
Zdravilo Clopidogrel Krka d.d. vsebuje hidrogenirano ricinusovo olje
Clopidogrel Krka d.d. is unlikely to affect your ability to drive or to use machines.
Ni verjetno, da bi zdravilo Clopidogrel Krka d.d. vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
Clopidogrel Krka is a medicine that contains the active substance clopidogrel.
Clopidogrel Krka je zdravilo, ki vsebuje zdravilno učinkovino klopidogrel.
Clopidogrel Krka is a ‘generic medicine’.
Zdravilo Clopidogrel Krka je „generično zdravilo“.
Clopidogrel Krka is unlikely to affect your ability to drive or to use machines.
Ni verjetno, da bi zdravilo Klopidogrel Krka vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
Clopidogrel Krka is used in adults to prevent atherothrombotic events (problems caused by blood clots and hardening of the arteries).
Zdravilo Clopidogrel Krka se uporablja pri odraslih za preprečevanje aterotrombotičnih dogodkov (težav, ki jih povzročajo krvni strdki in otrdelost arterij).
Clopidogrel Mylan 75 mg
Klopidogrel Mylan 75 mg
Clopidogrel Mylan 75 mg film-coated tablets
Klopidogrel Mylan 75 mg filmsko obložene tablete
Clopidogrel Mylan can be given to the following groups of patients: patients who have recently had a myocardial infarction (heart attack).
Zdravilo Clopidogrel Mylan se lahko daje naslednjim skupinam bolnikov: bolnikom, ki so nedavno doživeli miokardni infarkt (srčni napad).
Clopidogrel Mylan can be started between a few days and 35 days after the attack; patients who have had a recent ischaemic stroke (stroke caused by failure of the blood supply to part of the brain).
Zdravilo Clopidogrel Mylan se lahko začne jemati nekaj dni po napadu do 35 dni po njem; bolnikom, ki so nedavno utrpeli ishemično kap (kap, ki jo povzroči pomanjkljiva oskrba določenega dela možganov s krvjo).
Clopidogrel Mylan can be started between seven days and six months after the stroke; patients with peripheral arterial disease (problems with blood flow in the arteries).
Zdravilo Clopidogrel Mylan se lahko začne jemati od sedem dni po napadu do šest mesecev po njem; bolnikom s periferno arterijsko boleznijo (težavami s pretokom krvi v krvnih žilah).
Clopidogrel Mylan contains hydrogenated castor oil
Zdravilo Klopidogrel Mylan vsebuje hidrogenirano ricinusovo olje
Clopidogrel Mylan is a ‘generic medicine’.
Clopidogrel Mylan je „generično zdravilo“.
Clopidogrel Mylan is unlikely to affect your ability to drive or to use machines.
Ni verjetno, da bi zdravilo Klopidogrel Mylan vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
Clopidogrel N=5457
Klopidogrel N = 5.457
Clopidogrel N=5469
Klopidogrel N = 5.469
Clopidogrel N=9186
Klopidogrel n = 9186
Clopidogrel Qualimed 75 mg
Klopidogrel Qualimed 75 mg
Clopidogrel Qualimed 75 mg film-coated tablets
Klopidogrel Qualimed 75 mg filmsko obložene tablete
Clopidogrel Qualimed belongs to a group of medicines called antiplatelet medicinal products.
Klopidogrel Qualimed spada v skupino zdravil, ki se imenujejo zaviralci agregacije trombocitov.
Clopidogrel Qualimed can be given to the following groups of patients: patients who have recently had a myocardial infarction (heart attack).
Zdravilo Clopidogrel Qualimed se lahko daje naslednjim skupinam bolnikov: bolnikom, ki so nedavno doživeli miokardni infarkt (srčni napad).
Clopidogrel Qualimed can be started between a few days and 35 days after the attack; patients who have had a recent ischaemic stroke (stroke caused by failure of the blood supply to part of the brain).
Zdravilo Clopidogrel Qualimed se lahko začne jemati nekaj dni po napadu do 35 dni po njem; bolnikom, ki so nedavno utrpeli ishemično kap (kap, ki jo povzroči pomanjkljiva oskrba določenega dela možganov s krvjo).
Clopidogrel Qualimed can be started between seven days and six months after the stroke; patients with peripheral arterial disease (problems with blood flow in the arteries).
Zdravilo Clopidogrel Qualimed se lahko začne jemati od sedem dni po napadu do šest mesecev po njem; bolnikom s periferno arterijsko boleznijo (težavami s pretokom krvi v krvnih žilah).
Clopidogrel Qualimed is a ‘generic medicine’.
Clopidogrel Qualimed je „generično zdravilo“.
Clopidogrel Qualimed is unlikely to affect your ability to drive or to use machines.
Ni verjetno, da bi zdravilo Klopidogrel Qualimed vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
Clopidogrel Qualimed may be taken with or without food.
Zdravilo Klopidogrel Qualimed lahko jemljete s hrano ali brez nje.
Clopidogrel ratiopharm 75 mg film-coated tablets
Klopidogrel ratiopharm 75 mg filmsko obložene tablete
Clopidogrel ratiopharm 75 mg film-coated tablets are white to off-white, marbled, round and biconvex.
Klopidogrel ratiopharm 75 mg tablete so bele do belkaste, marmorirane, okrogle, bikonveksne filmsko obložene tablete.
Clopidogrel ratiopharm 75 mg film-coated tablets clopidogrel oral use
Klopidogrel ratiopharm 75 mg filmsko obložene tablete klopidogrel peroralna uporaba
Clopidogrel ratiopharm can also be used to prevent problems caused by blood clots in adults with atrial fibrillation (irregular rapid contractions of the upper chambers of the heart), when it should be given with aspirin.
Zdravilo Clopidogrel ratiopharm se lahko uporablja tudi za preprečevanje težav, ki jih povzročajo krvni strdki, pri odraslih z atrijsko fibrilacijo (nepravilnim, hitrim krčenjem preddvorov srca), in sicer skupaj z aspirinom.
Clopidogrel ratiopharm can be given to the following groups of patients: patients who have recently had a myocardial infarction (heart attack).
Lahko se daje naslednjim skupinam bolnikov: bolnikom, ki so nedavno doživeli miokardni infarkt (srčni napad).
Clopidogrel ratiopharm can be given to the following groups of patients: patients who have recently had a myocardial infarction (heart attack).
Zdravilo Clopidogrel ratiopharm se lahko daje naslednjim skupinam bolnikov: bolnikom, ki so nedavno doživeli miokardni infarkt (srčni napad).
Clopidogrel ratiopharm can be started between a few days and 35 days after the attack; patients who have had a recent ischaemic stroke (stroke caused by failure of the blood supply to part of the brain).
Zdravilo Clopidogrel ratiopharm se lahko začne jemati od nekaj dni po napadu do 35 dni po njem; bolnikom, ki so nedavno doživeli ishemično kap (kap, ki jo povzroči prekinitev dotoka krvi v del možganov).
Clopidogrel ratiopharm can be started between a few days and 35 days after the attack; patients who have had a recent ischaemic stroke (stroke caused by failure of the blood supply to part of the brain).
Zdravilo Clopidogrel ratiopharm se lahko začne jemati od nekaj dni po napadu do 35 dni po njem; bolnikom, ki so nedavno utrpeli ishemično kap (kap, ki jo povzroči pomanjkljiva oskrba določenega dela možganov s krvjo).
Clopidogrel ratiopharm can be started between seven days and six months after the stroke;
Zdravilo Clopidogrel ratiopharm se lahko začne jemati od sedem dni po kapi do šest mesecev po njej;
Clopidogrel ratiopharm can be started between seven days and six months after the stroke; patients with peripheral arterial disease (problems with blood flow in the arteries).
Zdravilo Clopidogrel ratiopharm se lahko začne jemati od sedem dni po napadu do šest mesecev po njem; bolnikom s periferno arterijsko boleznijo (težavami s pretokom krvi v krvnih žilah).
Clopidogrel ratiopharm can be used in patients who are having a heart attack with ‘ST segment elevation’ (an abnormal reading on the ECG or electrocardiogram) when the doctor thinks that they would benefit from the treatment.
Zdravilo Clopidogrel ratiopharm se lahko uporablja pri bolnikih, ki imajo srčni napad z „dvigom spojnice ST“ (nenormalnim zapisom na EKG ali elektrokardiogramu), če zdravnik meni, da bi jim zdravilo pomagalo.
Clopidogrel ratiopharm can only be obtained with a prescription.
Izdaja zdravila Clopidogrel ratiopharm je le na recept.